How Does Semax Work?
Semax is a synthetic heptapeptide — a chain of seven amino acids — designed as an analog of ACTH 4-10, a fragment of adrenocorticotropic hormone. Developed in Russia in the 1980s, it was engineered to retain neurotropic activity while eliminating hormonal effects on cortisol production. Researchers have studied it for decades because of its interactions with neurotrophic factor signaling.
A Neuropeptide by Design
Semax was not discovered in nature — it was designed. Scientists at the Institute of Molecular Genetics took the 4-10 fragment of ACTH (a hormone involved in stress response) and modified it to create a stable peptide that interacts with the nervous system without triggering the hormonal cascade that full-length ACTH produces. This rational design approach made Semax one of the earliest examples of a purpose-built neuropeptide for research applications. The result was a compound that researchers could use to study neurotrophic pathways without the confounding variable of cortisol changes.
Research Areas
Key areas of investigation documented in the published literature.
BDNF Research
The most significant finding in Semax research came in 2006, when Dolotov et al. published a study demonstrating that Semax regulates BDNF (brain-derived neurotrophic factor) and TrkB receptor expression in rat hippocampus and cortex. BDNF is one of the most important neurotrophic factors — a protein that supports the survival, growth, and differentiation of neurons. By establishing a connection between a synthetic peptide and endogenous neurotrophic signaling, this research opened new avenues for studying how external molecules can influence the brain's own growth and maintenance systems.
Neuroprotective Pathway Research
Beyond BDNF, researchers have explored Semax's interactions with broader neuroprotective pathways. Transcriptomic studies using microarray technology revealed that Semax affects the expression of hundreds of genes in brain tissue, including those involved in immune response, neurotransmitter metabolism, and vascular function. Later research expanded into additional neurotrophic factors — NGF and CNTF — and explored how melanocortin receptor activation interacts with immune modulation in neural tissue. This body of work positions Semax as a research tool for studying the intersection of peptide signaling and neural resilience.
Explore the Research
Dive deeper into the published literature and compound profiles.
Related Questions
Continue exploring peptide research topics.
What Is Selank?
Selank is a synthetic heptapeptide derived from tuftsin studied for GABAergic signaling, immune modulation, and stress adaptation research.
Read moreWhat Is MOTS-C?
MOTS-c is a mitochondrial-derived peptide studied for metabolic signaling, stress adaptation, and energy regulation. Learn what researchers have discovered.
Read moreWhat Does BPC-157 Do?
BPC-157 is a research peptide studied for its role in tissue repair signaling, angiogenesis, and connective tissue research. Learn what scientists have documented.
Read moreWhat Is PT-141?
PT-141 (Bremelanotide) is a melanocortin receptor agonist studied for central nervous system signaling. Learn about its research history and mechanism.
Read moreFor laboratory research use only. This content is provided for educational purposes about ongoing scientific research. Not for human consumption.